Nuveen Asset Management LLC Boosts Stock Position in Oscar Health, Inc. (NYSE:OSCR)

Nuveen Asset Management LLC boosted its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 1.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,356,298 shares of the company's stock after acquiring an additional 23,237 shares during the period. Nuveen Asset Management LLC owned 0.95% of Oscar Health worth $31,669,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. Integral Health Asset Management LLC acquired a new position in Oscar Health in the fourth quarter valued at approximately $9,408,000. Jacobs Levy Equity Management Inc. lifted its holdings in Oscar Health by 37.8% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company's stock valued at $23,403,000 after acquiring an additional 477,634 shares during the last quarter. Graham Capital Management L.P. lifted its holdings in Oscar Health by 182.1% in the fourth quarter. Graham Capital Management L.P. now owns 128,077 shares of the company's stock valued at $1,721,000 after acquiring an additional 82,673 shares during the last quarter. Focus Partners Wealth acquired a new position in Oscar Health in the fourth quarter valued at approximately $729,000. Finally, Ensign Peak Advisors Inc lifted its holdings in Oscar Health by 10.5% in the fourth quarter. Ensign Peak Advisors Inc now owns 43,022 shares of the company's stock valued at $578,000 after acquiring an additional 4,100 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the sale, the director now owns 64,512 shares of the company's stock, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 24.39% of the stock is owned by corporate insiders.

Oscar Health Trading Up 6.1%

NYSE OSCR traded up $0.86 on Tuesday, reaching $15.03. The stock had a trading volume of 8,061,517 shares, compared to its average volume of 4,326,575. The firm has a market capitalization of $3.77 billion, a price-to-earnings ratio of -751.12 and a beta of 1.75. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.79. The stock has a fifty day moving average price of $13.73 and a two-hundred day moving average price of $14.59.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. The company had revenue of $3 billion for the quarter, compared to analyst estimates of $2.87 billion. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The firm's quarterly revenue was up 42.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.62 earnings per share. As a group, sell-side analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Wall Street Zen cut Oscar Health from a "buy" rating to a "hold" rating in a report on Thursday, May 22nd. Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their price objective for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating, two have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, Oscar Health currently has a consensus rating of "Hold" and an average price target of $20.08.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.